Rehabilitation therapy
Rehabilitation therapy has been studied in 9 papers since 2018: 5 trials and 3 observational studies in people; 3 in the past year. The newest paper, Mar 13, 2026: “The role of early intervention with upper limb rehabilitation robots in upper limb functional reconstruction and improving sarcopenia-related indicators in stroke patients”.
9 papers study it9 findingsUpdated
See all 9 papers on rehabilitation therapy
At a glance
Independent labs found the same change in people. 5 independent labs in 3 countries.
“mean (SD) cumulative costs per patient were $26 421 ($38 955) in the intervention group (excluding intervention costs) and $27 650 ($30 712) in the control group (difference, -$1229; 95% CI, -$8159 to $6394; P = .80)”
None of its findings points the other way.
- 5 independent labs in 3 countries
- Funders: National Institute on Aging and 8 more
- 4 of 9 findings with company ties
- Human trial5
- Humans3
Studies in people
2 studies gave rehabilitation therapy to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on cumulative medical costsdifference, -$1229; 95% CI, -$8159 to $6394 up: Improves quality of lifemean utility difference, 0.074 | Randomized trial6 months | 349 peopleBoth60 years or olderOlder adults; acute decompensated heart failure | JAMA cardiology, Nov 25, 2021 |
up: Improves physical function+1.9 (95% CI: 1.1-2.6) up: Improves global rank of death, all-cause rehospitalization, and SPPBprobability index 0.59 (95% CI: 0.50-0.68) | Randomized trial3 months | 185 peopleBotholderOlder adults; HFpEF | JACC. Heart failure, Jul 7, 2021 |
What did studies of rehabilitation therapy find?
8Studies of rehabilitation therapy measured 8 outcomes, among them quality of life, inflammation and apelin.
Quality of life
upin humans2
2 studies
Quality of life
upin humans2
Rehabilitation therapy improves quality of life in humans (acute decompensated heart failure) (mean utility difference, 0.074).
Human trialacute decompensated heart failure6 monthsn = 349
Rehabilitation therapy is linked with better quality of life in humans (before and after 4-6 weeks of rehabilitation) (p < 0.001).
Humansbefore and after 4-6 weeks of rehabilitation4-6 weeksn = 23
Inflammation
downin humans1
1 study
Inflammation
downin humans1
Rehabilitation therapy is linked with lower inflammation in humans (cytokine profiles after rehabilitation).
Humanscytokine profiles after rehabilitation4-6 weeksn = 23
Apelin
upin humans1
1 study
Apelin
upin humans1
Rehabilitation therapy is linked with higher apelin in humans (before and after 4-6 weeks of rehabilitation) (46.81 to 59.23 ng/mL).
Humansbefore and after 4-6 weeks of rehabilitation4-6 weeksn = 23
Functional recovery
upin humans1
1 study
Functional recovery
upin humans1
Rehabilitation therapy is linked with better functional recovery in humans (subacute stroke) (B=1.289, β=0.290, 95% CIs: 0.718-1.859, P<0.001).
Humanssubacute stroke
Cumulative medical costs
no changein humans1
1 study
Cumulative medical costs
no changein humans1
Rehabilitation therapy showed no clear effect on cumulative medical costs in humans (acute decompensated heart failure) (difference, -$1229; 95% CI, -$8159 to $6394).
Human trialacute decompensated heart failure6 monthsn = 349
Activities of daily living
upin humans1
1 study
Activities of daily living
upin humans1
Rehabilitation therapy is linked with better activities of daily living in humans during rehabilitation therapy.
Humansduring rehabilitation therapy3 weeksfemales
Global rank of death, all-cause rehospitalization, and SPPB
upin humans1
1 study
Global rank of death, all-cause rehospitalization, and SPPB
upin humans1
Rehabilitation therapy improves global rank of death, all-cause rehospitalization, and SPPB in humans (HFpEF) (probability index 0.59 (95% CI: 0.50-0.68)).
Human trialHFpEF6 monthsn = 185
Physical function
upin humans1
1 study
Physical function
upin humans1
Rehabilitation therapy improves physical function in humans (HFpEF) (+1.9 (95% CI: 1.1-2.6)).
Human trialHFpEF3 monthsn = 185
Funding
3 grants since 2018National Institute on Aging$1.5MUK Research and Innovation£50.3K
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
National Institute on AgingUniversity of Florida$225K2022–2024
UK Research and InnovationUniversity of Leeds£50.3K2021–2022
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
National Institute on AgingWake Forest University Health Sciences$1.3M2014–2022
Contains public sector information licensed under the Open Government Licence v3.0.